Identification of clinical molecular targets for childhood Burkitt lymphoma

Burkitt lymphoma (BL) is a malignant tumor in children. Although BL is generally curable, early relapse and refractoriness may occur. Some molecular indicators have been recently suggested for BL diagnosis, but large heterogeneity still exists. This study aimed at providing clinical molecular target...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Meng, Leijun, Jiang, Weiyun, Zhang, Hong, Zhou, Aiwu, Zeng, Naiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502376/
https://www.ncbi.nlm.nih.gov/pubmed/32947237
http://dx.doi.org/10.1016/j.tranon.2020.100855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502376/
https://www.ncbi.nlm.nih.gov/pubmed/32947237
http://dx.doi.org/10.1016/j.tranon.2020.100855

Ejemplares similares